SQUAMOUS CELL LUNG CANCER
Clinical trials for SQUAMOUS CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new SQUAMOUS CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for SQUAMOUS CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug targets rare lung cancer gene in small trial
Disease control Recruiting nowThis phase 2 trial is testing a drug called ZEN003694 in 13 people with advanced squamous cell lung cancer that has a specific gene change (NSD3 amplification). The drug works by blocking certain proteins that may help the cancer grow. Researchers want to see if it can shrink tum…
Matched conditions: SQUAMOUS CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Engineered immune cells take on Hard-to-Treat lung cancer
Disease control Recruiting nowThis early-stage trial tests a new treatment called C-CAR031 for people with advanced squamous cell lung cancer that has stopped responding to standard therapies. The treatment uses a patient's own immune cells, modified in a lab to better recognize and attack cancer cells. The m…
Matched conditions: SQUAMOUS CELL LUNG CANCER
Phase: PHASE1 • Sponsor: Shanghai AbelZeta Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC